These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Treatment benefit of dapoxetine for premature ejaculation: results from a placebo-controlled phase III trial. Kaufman JM; Rosen RC; Mudumbi RV; Tesfaye F; Hashmonay R; Rivas D BJU Int; 2009 Mar; 103(5):651-8. PubMed ID: 19021601 [TBL] [Abstract][Full Text] [Related]
14. A benefit-risk assessment of dapoxetine in the treatment of premature ejaculation. Hutchinson K; Cruickshank K; Wylie K Drug Saf; 2012 May; 35(5):359-72. PubMed ID: 22452563 [TBL] [Abstract][Full Text] [Related]
15. Premature ejaculation and pharmaceutical company-based medicine: the dapoxetine case. Waldinger MD; Schweitzer DH J Sex Med; 2008 Apr; 5(4):966-997. PubMed ID: 18371047 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials. McMahon CG; Althof SE; Kaufman JM; Buvat J; Levine SB; Aquilina JW; Tesfaye F; Rothman M; Rivas DA; Porst H J Sex Med; 2011 Feb; 8(2):524-39. PubMed ID: 21059176 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study. McMahon CG; Giuliano F; Dean J; Hellstrom WJ; Bull S; Tesfaye F; Sharma O; Rivas DA; Aquilina JW J Sex Med; 2013 Sep; 10(9):2312-25. PubMed ID: 23845016 [TBL] [Abstract][Full Text] [Related]
19. Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetine. McMahon C; Kim SW; Park NC; Chang CP; Rivas D; Tesfaye F; Rothman M; Aquilina J; J Sex Med; 2010 Jan; 7(1 Pt 1):256-68. PubMed ID: 19878447 [TBL] [Abstract][Full Text] [Related]